Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01226004
What this trial is testing

Multi-Institutional Registry for Prostate Cancer Radiosurgery

Who this might be right for
Prostate Cancer Early Risk Treated by RadiosurgeryProstate Cancer Intermediate Risk Treated by Radiosurgery
RPCR, Inc. 3,000
Not applicableStudy completedNCT03368547
What this trial is testing

68Ga-PSMA-11 PET/CT in Imaging Patients With Intermediate or High Risk Prostate Cancer Before Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer AJCC v7Stage III Prostate Cancer AJCC v7+1 more
Jonsson Comprehensive Cancer Center 400
Large-scale testing (Phase 3)Study completedNCT03388346
What this trial is testing

68Ga PSMA in Preprostatectomy Patients

Who this might be right for
Prostate CancerProstatic NeoplasmProstatic Neoplasms, Castration-Resistant+1 more
Michael Graham PhD, MD 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04197141
What this trial is testing

Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 58
Large-scale testing (Phase 3)Study completedNCT04627896
What this trial is testing

Targeted Microwave Focal Therapy

Who this might be right for
Prostate Cancer Stage I
A.O.U. Città della Salute e della Scienza 11
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Large-scale testing (Phase 3)Active Not RecruitingNCT01368588
What this trial is testing

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 2,590
Not applicableLooking for participantsNCT07343349
What this trial is testing

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Who this might be right for
Prostate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate CarcinomaLocally Advanced Prostate Cancer+1 more
Rigshospitalet, Denmark 1,016
Testing effectiveness (Phase 2)UnknownNCT02342054
What this trial is testing

Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Hospital de Cruces 49
Testing effectiveness (Phase 2)Looking for participantsNCT06461819
What this trial is testing

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy With SPACEOAR TM for Patients With Low-to-intermediate Risk Localized Prostate Cancer (DESAR-L)

Who this might be right for
Low-to-intermediate-risk Prostate Carcinoma
Samsung Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT01517451
What this trial is testing

Radiation and Androgen Ablation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Not applicableUnknownNCT03340272
What this trial is testing

PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.

Who this might be right for
Intermediate Risk Prostate CancerHigh Risk Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084
What this trial is testing

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Who this might be right for
Prostate Adenocarcinoma
NRG Oncology 2,050
Not applicableLooking for participantsNCT07339943
What this trial is testing

Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness

Who this might be right for
Prostate Cancer (Adenocarcinoma)Low and Intermediate Risk Prostate Cancer
University Health Network, Toronto 7
Not applicableEnded earlyNCT00619515
What this trial is testing

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 73
Not applicableStudy completedNCT01982786
What this trial is testing

Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Canadian Cancer Trials Group 57
Not applicableNot Yet RecruitingNCT07526675
What this trial is testing

Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

Who this might be right for
Prostate CancerLower Urinary Tract Symptoms (LUTS)Benign Prostatic Hyperplasia
Benha University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05454488
What this trial is testing

An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)WithdrawnNCT04569461
What this trial is testing

Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

Who this might be right for
Prostate Cancer
Duke University
Not applicableWithdrawnNCT03514927
What this trial is testing

High-Intensity Focused Ultrasound in Treating Participants With Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer Stage I AJCC V6Prostate Cancer Stage IIProstate Cancer Stage III
University of Southern California
Next Page